Condition
Hepatitis B
Hepatitis B is a viral infection of the liver that can be short-lived or become chronic, lasting more than six months. Among supplements, thymosin alpha-1 has the strongest evidence, and three trials with about 520 people found that liver enzyme (ALT) levels returned to normal more often. Vitamin D and vitamin E have also been studied, but evidence for both is limited so far.
Sources: PMID 9581695; PMID 10607256
- Supplements studied
- 0
- Medicines and peptides
- 1
- Graded outcomes
- 3
No supplement studies yetWe haven’t found supplement studies for Hepatitis B. The medicines and peptides studied for it are listed below.
Prescription medicines and peptides studied, for context
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| HBeAg Seroconversion Moderate Improvement | Improves (the measure goes up) | Moderate effect | 3 studies | 485 people | ||
Studies that measured hbeag seroconversion | ||||||
| ALT Normalization Moderate Improvement | Improves (the measure goes down) | Moderate effect | 3 studies | 520 people | ||
Studies that measured alt normalization | ||||||
| HBV DNA Clearance Moderate Improvement | Improves (the measure goes up) | Moderate effect | 3 studies | 380 people | ||
Studies that measured hbv dna clearance | ||||||
Key findings
- HBeAg SeroconversionImproves (the measure goes up)
- ALT NormalizationImproves (the measure goes down)
- HBV DNA ClearanceImproves (the measure goes up)
The Hepatitis B Supportive Care protocol
2 primary supplements · 3 supporting supplements
Studies cited
3 studies from PubMed